• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在原始或奥密克戎 BA.1 SARS-CoV-2 感染期间的病毒脱落动力学,以及在突破感染期间增强预先存在的免疫。

Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections.

机构信息

CIRI, Centre International de Recherche en Infectiologie, Team VirPath, Univ Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, Lyon, France.

Joint Research Unit Civils Hospices of Lyon-bioMérieux, Civils Hospices of Lyon, Lyon Sud Hospital, Pierre-Bénite, France.

出版信息

Emerg Microbes Infect. 2022 Dec;11(1):2423-2432. doi: 10.1080/22221751.2022.2122578.

DOI:10.1080/22221751.2022.2122578
PMID:36098494
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9621261/
Abstract

Omicron variant is circulating in the presence of a globally acquired immunity unlike the ancestral SARS-CoV-2 isolate. Herein, we investigated the normalized viral load dynamics and viral culture status in 44 fully vaccinated healthcare workers (HCWs) infected with the Omicron BA.1 variant. Viral load dynamics of 38 unvaccinated HCWs infected with the 20A variant during the first pandemic wave was also studied. We then explored the impact of Omicron infection on pre-existing immunity assessing anti-RBD IgG levels, neutralizing antibody titres against 19A, Delta and Omicron isolates, as well as IFN-γ release following cell stimulation with SARS-CoV-2 peptides. We reported that two weeks after diagnosis a greater proportion of HCWs infected with 20A (78.9%, 15/19) than with Omicron BA.1 (44.7%, 17/38; p = 0.02) were still positive by RT-qPCR. We found that Omicron breakthrough infections led to an overall enhancement of vaccine-induced humoral and cellular immunity as soon as a median [interquartile range] of 8 [7-9] days post symptom onset. Among samples with similar high viral loads, non-culturable samples exhibited higher neutralizing antibody titres and anti-RBD IgG levels than culturable samples. Additionally, Omicron infection led to an enhancement of antibodies neutralization capacity against other SARS-CoV-2 isolates. Taken together, the results suggest that Omicron BA.1 vaccine breakthrough infection is associated with a faster viral clearance than that of the ancestral SARS-CoV-2, in addition this new variant leads to a rapid enhancement of the humoral response against multiple SARS-CoV-2 variants, and of the cellular response.

摘要

奥密克戎变异株在全球获得性免疫存在的情况下传播,这与原始 SARS-CoV-2 分离株不同。在此,我们研究了 44 名完全接种疫苗的医护人员(HCWs)感染奥密克戎 BA.1 变异株后病毒载量的动态变化和病毒培养情况。我们还研究了在第一次大流行期间,38 名未接种疫苗的 HCWs 感染 20A 变异株的病毒载量动态。然后,我们通过评估抗 RBD IgG 水平、针对 19A、Delta 和 Omicron 分离株的中和抗体滴度以及用 SARS-CoV-2 肽刺激细胞后 IFN-γ 的释放,来探讨奥密克戎感染对预先存在的免疫的影响。我们报告称,与 Omicron BA.1(44.7%,17/38)相比,感染 20A 的 HCWs 在诊断后两周仍通过 RT-qPCR 检测为阳性的比例更高(78.9%,15/19;p=0.02)。我们发现,奥密克戎突破性感染导致了疫苗诱导的体液和细胞免疫的全面增强,中位数 [四分位距]为症状出现后 8 [7-9] 天。在具有相似高病毒载量的样本中,非可培养样本的中和抗体滴度和抗 RBD IgG 水平高于可培养样本。此外,奥密克戎感染导致对其他 SARS-CoV-2 分离株的抗体中和能力增强。总之,这些结果表明,与原始 SARS-CoV-2 相比,奥密克戎 BA.1 疫苗突破性感染与更快的病毒清除相关,此外,这种新变异株导致对多种 SARS-CoV-2 变异株的体液反应和细胞反应的快速增强。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2b3/9621261/aad978fd7b26/TEMI_A_2122578_F0004_OB.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2b3/9621261/83b27599f4a3/TEMI_A_2122578_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2b3/9621261/beb0589eff06/TEMI_A_2122578_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2b3/9621261/fdedef714839/TEMI_A_2122578_F0003_OB.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2b3/9621261/aad978fd7b26/TEMI_A_2122578_F0004_OB.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2b3/9621261/83b27599f4a3/TEMI_A_2122578_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2b3/9621261/beb0589eff06/TEMI_A_2122578_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2b3/9621261/fdedef714839/TEMI_A_2122578_F0003_OB.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2b3/9621261/aad978fd7b26/TEMI_A_2122578_F0004_OB.jpg

相似文献

1
Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections.在原始或奥密克戎 BA.1 SARS-CoV-2 感染期间的病毒脱落动力学,以及在突破感染期间增强预先存在的免疫。
Emerg Microbes Infect. 2022 Dec;11(1):2423-2432. doi: 10.1080/22221751.2022.2122578.
2
Pre-Omicron Vaccine Breakthrough Infection Induces Superior Cross-Neutralization against SARS-CoV-2 Omicron BA.1 Compared to Infection Alone.奥密克戎变异株疫苗突破性感染诱导针对 SARS-CoV-2 奥密克戎 BA.1 的交叉中和反应优于单独感染。
Int J Mol Sci. 2022 Jul 12;23(14):7675. doi: 10.3390/ijms23147675.
3
Distinct features of SARS-CoV-2 humoral immunity against Omicron breakthrough infection.奥密克戎突破性感染中针对 SARS-CoV-2 体液免疫的独特特征。
Vaccine. 2023 Nov 13;41(47):7019-7025. doi: 10.1016/j.vaccine.2023.10.035. Epub 2023 Oct 17.
4
Prototype and BA.5 protein nanoparticle vaccines protect against Omicron BA.5 variant in Syrian hamsters.原型和 BA.5 蛋白纳米颗粒疫苗可预防叙利亚仓鼠感染奥密克戎 BA.5 变异株。
J Virol. 2024 Mar 19;98(3):e0120623. doi: 10.1128/jvi.01206-23. Epub 2024 Feb 2.
5
Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5.COVID-19 患者在突破感染 SARS-CoV-2 变异株 Delta、Omicron-BA.1 和 Omicron-BA.5 期间的免疫反应。
Front Immunol. 2023 Jul 13;14:1150667. doi: 10.3389/fimmu.2023.1150667. eCollection 2023.
6
Trends of humoral immune responses to heterologous antigenic exposure due to vaccination & omicron SARS-CoV-2 infection: Implications for boosting.由于疫苗接种和奥密克戎 SARS-CoV-2 感染导致的针对异源抗原暴露的体液免疫反应趋势:对增强作用的影响。
Indian J Med Res. 2023 Jun;157(6):509-518. doi: 10.4103/ijmr.ijmr_2521_22.
7
Determinants of protection against SARS-CoV-2 Omicron BA.1 and Delta infections in fully vaccinated outpatients.完全接种疫苗的门诊患者中针对 SARS-CoV-2 奥密克戎 BA.1 和德尔塔感染的保护因素。
J Med Virol. 2023 Aug;95(8):e28984. doi: 10.1002/jmv.28984.
8
Neutralizing Antibody Responses against Five SARS-CoV-2 Variants and T Lymphocyte Change after Vaccine Breakthrough Infections from the SARS-CoV-2 Omicron BA.1 Variant in Tianjin, China: A Prospective Study.中国天津地区针对 SARS-CoV-2 奥密克戎 BA.1 变异株疫苗突破性感染后五种 SARS-CoV-2 变异株的中和抗体反应和 T 淋巴细胞变化的前瞻性研究。
Biomed Environ Sci. 2023 Jul 20;36(7):614-624. doi: 10.3967/bes2023.047.
9
Ancestral SARS-CoV-2 and Omicron BA.5-specific neutralizing antibody and T-cell responses after Omicron bivalent booster vaccination in previously infected and infection-naive individuals.先前感染和未感染个体接种奥密克戎二价加强针后针对原始 SARS-CoV-2 和奥密克戎 BA.5 的中和抗体和 T 细胞应答。
J Med Virol. 2023 Aug;95(8):e28989. doi: 10.1002/jmv.28989.
10
Viral kinetics of SARS-CoV-2 following onset of COVID-19 in symptomatic patients infected with the ancestral strain and omicron BA.2 in Hong Kong: a retrospective observational study.新冠病毒感染后症状患者中,新冠病毒(SARS-CoV-2)的病毒动力学:对香港感染原始株和奥密克戎 BA.2 患者的回顾性观察研究。
Lancet Microbe. 2023 Sep;4(9):e722-e731. doi: 10.1016/S2666-5247(23)00146-5.

引用本文的文献

1
Comparative Effectiveness of Antiviral Agents and Monoclonal Antibodies for Early SARS-CoV-2 Therapy in Immunocompromised Patients: A Multicenter Retrospective Cohort Study (March 2021-March 2022).免疫功能低下患者早期新冠病毒治疗中抗病毒药物和单克隆抗体的比较疗效:一项多中心回顾性队列研究(2021年3月至2022年3月)
Microorganisms. 2025 May 6;13(5):1076. doi: 10.3390/microorganisms13051076.
2
Clinical characteristics and host immunity responses of SARS-CoV-2 Omicron variant BA.2 with deletion of ORF7a, ORF7b and ORF8.奥密克戎变异株 BA.2 缺失 ORF7a、ORF7b 和 ORF8 后的临床特征和宿主免疫反应。
Virol J. 2023 May 29;20(1):106. doi: 10.1186/s12985-023-02066-3.
3

本文引用的文献

1
Detection and prevalence of SARS-CoV-2 co-infections during the Omicron variant circulation in France.法国奥密克戎变异株流行期间 SARS-CoV-2 合并感染的检测和流行情况。
Nat Commun. 2022 Oct 23;13(1):6316. doi: 10.1038/s41467-022-33910-9.
2
Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection.新型冠状病毒奥密克戎(BA.1)感染中可培养病毒的脱落持续时间。
N Engl J Med. 2022 Jul 21;387(3):275-277. doi: 10.1056/NEJMc2202092. Epub 2022 Jun 29.
3
Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals.
Comparison of antibody responses to SARS-CoV-2 variants in Australian children.
澳大利亚儿童对 SARS-CoV-2 变异株的抗体反应比较。
Nat Commun. 2022 Nov 23;13(1):7185. doi: 10.1038/s41467-022-34983-2.
接种疫苗和未接种疫苗个体中的 SARS-CoV-2 传播和传染性脱落动力学。
JAMA Netw Open. 2022 May 2;5(5):e2213606. doi: 10.1001/jamanetworkopen.2022.13606.
4
Omicron infection enhances Delta antibody immunity in vaccinated persons.奥密克戎感染可增强接种者体内针对德尔塔变异株的抗体免疫。
Nature. 2022 Jul;607(7918):356-359. doi: 10.1038/s41586-022-04830-x. Epub 2022 May 6.
5
Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2.未接种疫苗和接种疫苗的个体中感染原始、Delta 或奥密克戎 SARS-CoV-2 的传染性病毒载量。
Nat Med. 2022 Jul;28(7):1491-1500. doi: 10.1038/s41591-022-01816-0. Epub 2022 Apr 8.
6
The effective reproductive number of the Omicron variant of SARS-CoV-2 is several times relative to Delta.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)奥密克戎变异株的有效繁殖数相对于德尔塔变异株而言是其数倍。
J Travel Med. 2022 May 31;29(3). doi: 10.1093/jtm/taac037.
7
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.广谱中和抗体可克服 SARS-CoV-2 奥密克戎抗原漂移。
Nature. 2022 Feb;602(7898):664-670. doi: 10.1038/s41586-021-04386-2. Epub 2021 Dec 23.
8
Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons.接种疫苗和未接种疫苗人群中新冠病毒变异株的病毒动力学
N Engl J Med. 2021 Dec 23;385(26):2489-2491. doi: 10.1056/NEJMc2102507. Epub 2021 Dec 1.
9
Specific detection of memory T-cells in COVID-19 patients using standardized whole-blood Interferon gammarelease assay.使用标准化全血干扰素γ释放试验对COVID-19患者的记忆T细胞进行特异性检测。
Eur J Immunol. 2021 Dec;51(12):3239-3242. doi: 10.1002/eji.202149296. Epub 2021 Sep 6.
10
Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study.有症状的疑似 COVID-19 医护人员的临床和实验室特征:一项前瞻性队列研究。
Sci Rep. 2021 Jul 22;11(1):14977. doi: 10.1038/s41598-021-93828-y.